Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review Report

Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review Report
14-11-2019
Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for Unaudited Standalone Financial Results Of The Company For The Quarter Ended September 30, 2019 Along With Limited Review Report Thereon

RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Unaudited Standalone Financial Results of the Company for the Quarter ended September 30, 2019 along with Limited Review Report thereon
06-11-2019
Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Compliance Certificate For The Half Year Ended September 30, 2019

Compliance certificate for the half year ended September 30, 2019
25-10-2019
Bigul

Rubra Medicaments Ltd - 531099 - Shareholding for the Period Ended September 30, 2019

Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
19-10-2019
Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Compliance Certificate For The Half Year Ended September 30, 2019

Compliance Certificate For The Half Year Ended September 30, 2019
19-10-2019
Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- Director
05-10-2019
Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Rubra Medicaments Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-10-2019
Bigul

Rubra Medicaments Ltd - 531099 - Notice Of 28Th Annual General Meeting Of The Company

Notice of 28th Annual General Meeting of the Company
04-09-2019
Bigul

RUBRA MEDICAMENTS LTD. - 531099 - Reg. 34 (1) Annual Report

Annual Report of the Company for the FY 2018-19
03-09-2019
Next Page
Close

Let's Open Free Demat Account